Similarly, another study reported that DNMTI 5-Aza-2′-deoxycytidine (DAC) treatment on AML patient samples and cell lines demonstrated a reduction in TERT expression and telomerase activity [132]. The gene discussed is TERT; the disease is acute myeloid leukemia.